News | March 07, 2023
Sun Pharma completes acquisition of Concert Pharmaceuticals
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
Jan Aushadhi Diwas celebrations to generate awareness about the usages of generic medicines and benefits of Jan Aushadhi Pariyojana
This order is subject to initial advance payment as per the agreed terms of the contract
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
Projected ~US$100 million cash balance of combined company expected to fund operations through mid-2025 and to clinical data over the next 12 to 24 months
This artificial RNA ligase has higher thermostability than natural RNA ligase
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
